Open Internet by MindsNet

Mitigating Muscle Loss in Obesity Treatment

The use of obesity drugs like semaglutide and tirzepatide may lead to significant muscle mass loss in patients, in addition to fat loss. This muscle loss may be a part of overall weight loss rather than a specific side effect of these drugs. There is a need to understand and address this issue to improve treatment outcomes.

Science, Medicine, Pharmacology